ClinicalTrials.Veeva

Menu

Improving Medication Adherence: A Study With Talking Pill Bottles (TPB)

University of Washington logo

University of Washington

Status

Completed

Conditions

Medication Adherence

Treatments

Other: Talking Pill Bottle

Study type

Interventional

Funder types

Other

Identifiers

NCT02827773
35077-G

Details and patient eligibility

About

The aim of this research project is to compare the use of "Talking Pill Bottles" to usual care in patients who have low functional health literacy and who purchase medications for primary hypertension at a retail pharmacy with regard to:

  1. feasibility of the procedures,
  2. utility of the equipment,
  3. medication adherence,
  4. self efficacy in medication self management, and
  5. blood pressure control.

Full description

Introduction: Across the healthcare continuum, patients with low functional health literacy may have worse outcomes due to difficulties in following prescribed medication regimens. While reasons for non-adherence can be drawn from the intra-personal, interpersonal, and systemic perspectives; one starting point is the difficulty that patients have reading and understanding medication instructions on a prescription bottle labels. Labels can provide a vital reminder and decision support aid for patients and healthcare proxies. Yet, skills must be available for reading and understanding the labels. The investigators will utilize "Talking Pill Bottles" to record prescription medication instructions so that patients can re-play the instructions as needed in their homes. Purpose: The aim of this research project is to compare the use of "Talking Pill Bottles" to usual care in patients who have low functional health literacy and who purchase medications for primary hypertension at a retail pharmacy with regard to: a. feasibility of the procedures, b. utility of the equipment, c. medication adherence, d. self efficacy in medication self management, and e. blood pressure control. Design: This novel intervention will be tested within the context of a retail pharmacy in the Pacific Northwest. The pilot test will use a randomized trial design with two research arms. Analysis: Within-group change scores on a self efficacy measure and blood pressures will be examined with the paired t-test; between group measures will also be examined between the two treatment arms. The investigators will also track medication complexity as a potential confounder and conduct semi-structured exit interviews. Conclusion: Results will help establish the feasibility and utility of providing this technology to patients who have low functional health literacy in a retail pharmacy. The investigators will gather preliminary descriptive data along with variance and effect size measures for power estimations in a future multi-site, randomized controlled trial.

Enrollment

138 patients

Sex

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 21 years or older
  • Filling a prescription for hypertension treatment
  • Able to understand spoken English.

Exclusion criteria

  • Cannot understand English;
  • Hearing impaired when not using hearing assistive devices
  • Cognitively impaired.
  • Unable to read labels with corrected vision

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

138 participants in 2 patient groups

Received Talking Pill Bottles
Experimental group
Description:
Patients received anti-hypertensives over 90 day period in Talking Pill Bottle which contained summary of pharmacy counselling session.
Treatment:
Other: Talking Pill Bottle
Usual Care
No Intervention group
Description:
Patients received oral summary of pharmacy counselling session.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems